Cbz-QFR-kbt

Overview

Cbz-QFR-kbt is a ketone-based benzothiazole ketone inhibitor of TMPRSS2 , with an IC 50 value of 0.42 nM. Cbz-QFR-kbt also has inhibitory activity against Matriptase , Hepsin , HGFA , and Factor Xa , with IC 50 values of 1, 1.3, 85, and 85 nM respectively. Cbz-QFR-kbt shows significant inhibitory effects against SARS-CoV-2 and H1N1 ( IC 50 = 60 nM). Cbz-QFR-kbt can be used in antiviral research.

Application

Products | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Influenza Virus Infection | Products > Disease Areas > Infection | Products > Disease Areas > Viral Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Ser/Thr Protease | Products > Signaling Pathways > Factor Xa | Products > Signaling Pathways > SARS-CoV | Products > Signaling Pathways > Influenza Virus

Product Information

• Catalog No.: HY-179708
• CAS No.: 3086979-57-6
• Molecular Formula: C35H40N8O6S
• Molecular Weight: 700.81
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source